|
|
|
Insider
Information: |
Anzalone Christopher Richard |
Relationship: |
Chief Executive Office... |
City: |
Pasadena |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
3,715,048 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$95,736,787 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
3,715,048 |
|
|
Total
Value |
$95,736,787 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
4
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-4.0
|
Percentage
Gain/Loss : |
0.0%
|
-37.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Chief Executive Office... |
2024-01-31 |
3,715,048 |
2008-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-09-23 |
4 |
S |
$29.04 |
$1,212,565 |
D/D |
(41,755) |
2,141,903 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-05-24 |
4 |
OE |
$2.01 |
$105,110 |
D/D |
49,448 |
2,141,903 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-04-03 |
4 |
S |
$19.30 |
$965,000 |
D/D |
(50,000) |
2,092,455 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2020-08-13 |
4 |
OE |
$9.90 |
$495,000 |
D/D |
50,000 |
2,655,237 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2020-08-13 |
4 |
AS |
$41.35 |
$2,067,500 |
D/D |
(50,000) |
2,605,237 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2021-10-22 |
4 |
AS |
$65.57 |
$3,281,532 |
D/D |
(50,000) |
3,279,022 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-05-04 |
4 |
OE |
$2.01 |
$100,500 |
D/D |
50,000 |
3,811,338 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-05-04 |
4 |
S |
$38.97 |
$1,975,792 |
D/D |
(50,000) |
3,761,338 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-05-03 |
4 |
S |
$39.14 |
$2,149,882 |
D/D |
(54,928) |
3,761,338 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-05-03 |
4 |
OE |
$2.01 |
$110,405 |
D/D |
54,928 |
3,816,266 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-10-10 |
4 |
S |
$31.83 |
$1,792,825 |
D/D |
(56,325) |
2,121,903 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-10-10 |
4 |
OE |
$5.20 |
$292,890 |
D/D |
56,325 |
2,178,228 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2024-01-31 |
4 |
OE |
$14.54 |
$836,035 |
D/D |
57,499 |
3,772,547 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2024-01-31 |
4 |
AS |
$32.16 |
$1,860,019 |
D/D |
(57,499) |
3,715,048 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-09-18 |
4 |
AS |
$28.00 |
$1,624,223 |
D/D |
(57,755) |
3,761,338 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2023-09-18 |
4 |
OE |
$4.75 |
$274,336 |
D/D |
57,755 |
3,819,093 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2015-12-30 |
4 |
D |
$6.13 |
$359,905 |
D/D |
(58,712) |
561,461 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2021-12-15 |
4 |
AS |
$66.28 |
$4,053,431 |
D/D |
(60,000) |
3,219,022 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2018-09-04 |
4 |
AS |
$14.45 |
$936,851 |
D/D |
(64,834) |
1,803,955 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-09-24 |
4 |
S |
$28.00 |
$1,879,240 |
D/D |
(66,645) |
2,141,903 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-09-24 |
4 |
OE |
$5.10 |
$339,890 |
D/D |
66,645 |
2,208,548 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2018-11-09 |
4 |
AS |
$14.35 |
$1,172,705 |
D/D |
(81,500) |
1,722,455 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-12-13 |
4 |
AS |
$65.85 |
$5,560,489 |
D/D |
(83,333) |
1,888,570 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2019-12-24 |
4 |
AS |
$63.50 |
$5,291,646 |
D/D |
(83,333) |
1,805,237 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Chief Executive Officer |
|
2018-12-12 |
4 |
AS |
$14.07 |
$1,266,300 |
D/D |
(90,000) |
1,632,455 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|